DRKS00031066招募中不适用
Influencing factors on weight gain under mirtazapine? A restrospective analyses of routine data
VR-Klinik Düsseldorf0 个研究点目标入组 2,000 人开始时间: 2023年1月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one(—)
- 性别
- All
入选标准
- •patients, which were treated newly with mirtazapin for more than 28 days
排除标准
- •patients, which were already treated with mirtazapine
研究者
相似试验
已完成
不适用
Effect of Topiramate on body weight of patients with schizophrenia treated with OlanzapineSchizophrenia.SchizophreniaIRCT201402085280N15Mashhad University of Medical Sciences48
已完成
4 期
Weight Gain Management in Patients With SchizophreniaSchizophreniaNCT00486005Eli Lilly and Company74
已完成
不适用
Weight gain and appetite changes following treatment for thyrotoxicosis – a pilot studyThyrotoxicosisACTRN12616000843459Waikato Hospital20
已完成
不适用
Mirtazapine in Alzheimer-associated Weight LossAlzheimer's DiseaseWeight LossMixed DementiaDementiaNCT01505504Brugmann University Hospital22
已完成
不适用
Mirtazapine augmentation enhances cognitive and negative symptoms in schizophrenic patients treated with risperidone: a randomised controlled trialSchizophreniaISRCTN54975957Bundang CHA Hospital (South Korea)25
